EUVIMEDEUVIMED entdecken
Crossref

The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW‐CKD

Cheol Ho Park iD, Hyung Woo Kim, Jung Tak Park iD, Tae Ik Chang iD, Tae-Hyun Yoo, Sue Kyung Park, Yaeni Kim, Ji Yong Jung iD, Jong Cheol Jeong, Kook-Hwan Oh, Shin-Wook Kang, Seung Hyeok Han iD und 1 weitere

Journal of Internal Medicine · 2023

DOI: 10.1111/joim.13701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2023. Verfasst von Cheol Ho Park und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Blood Pressure, Hypertension, Antihypertensive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Korea Disease Control and Prevention Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The 2021 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure (BP) in chronic kidney disease (CKD) recommends a target systolic BP of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicBlood PressureHypertensionAntihypertensive AgentsHumansMaleDisease ProgressionFemaleMiddle AgedAgedGlomerular Filtration RateRepublic of KoreaPractice Guidelines as Topic

Stichwörter der Autor:innen

2021 KDIGOblood pressurechronic kidney diseasekidney outcome

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.
  • Department of Internal Medicine, National Health Insurance Service Medical Center, Ilsan Hospital, Goyang, Republic of Korea.
  • Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Division of Nephrology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

ORCID-Profile: Cheol Ho Park, Jung Tak Park, Tae Ik Chang, Ji Yong Jung, Seung Hyeok Han

Förderung

  • Korea Disease Control and Prevention Agency

Zitieren

APA

Park, C. H., Kim, H. W., Park, J. T., Chang, T. I., Yoo, T. H., Park, S. K., Kim, Y., Jung, J. Y., Jeong, J. C., Oh, K. H., Kang, S. W., Han, S. H., & KNOW-CKD (KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease) Investigators (2023). The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW‐CKD. Journal of Internal Medicine. https://doi.org/10.1111/joim.13701

Vancouver

Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Park SK, et al. The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW‐CKD. Journal of Internal Medicine. 2023. doi:10.1111/joim.13701

BibTeX
@article{Park2023,
  author = {Park, Cheol Ho and Kim, Hyung Woo and Park, Jung Tak and Chang, Tae Ik and Yoo, Tae-Hyun and Park, Sue Kyung and Kim, Yaeni and Jung, Ji Yong and Jeong, Jong Cheol and Oh, Kook-Hwan and Kang, Shin-Wook and Han, Seung Hyeok and KNOW-CKD (KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease) Investigators, KNOW-CKD (KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease) Investigators},
  title = {The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW‐CKD},
  journal = {Journal of Internal Medicine},
  year = {2023},
  doi = {10.1111/joim.13701}
}
Kostenlos starten →